rss
J Epidemiol Community Health 63:332-336 doi:10.1136/jech.2008.080382
  • Evidence-based public health policy and practice

Trends in the prevalence and incidence of diabetes in the UK: 1996–2005

  1. E L Massó González1,
  2. S Johansson2,3,
  3. M-A Wallander2,4,
  4. L A García Rodríguez1
  1. 1
    Spanish Centre for Pharmacoepidemiological Research (CEIFE), Madrid, Spain
  2. 2
    AstraZeneca R&D, Mölndal, Sweden
  3. 3
    Institute of Medicine, Sahlgrenska Academy Göteborg University, Sweden
  4. 4
    Department of Public Health and Caring Science, Uppsala University, Sweden
  1. Ms E L Massó González, Spanish Centre for Pharmacoepidemiological Research (CEIFE), Almirante 28, 2°, 28004 Madrid, Spain; elviraceife{at}telefonica.net
  • Accepted 9 December 2008
  • Published Online First 24 February 2009

Abstract

Background: To estimate the incidence and prevalence of type 1 and type 2 diabetes in the UK general population from 1996 to 2005.

Methods: Using The Health Improvement Network database, patients with type 1 or type 2 diabetes were identified who were 10–79 years old between 1996 and 2005. Prevalent cases (n = 49 999) were separated from incident cases (n = 42 642; type 1 = 1256, type 2 = 41 386). Data were collected on treatment patterns in incident cases, and on body mass index in prevalent and incident cases.

Results: Diabetes prevalence increased from 2.8% in 1996 to 4.3% in 2005. The incidence of diabetes in the UK increased from 2.71 (2.58–2.85)/1000 person-years in 1996 to 4.42 (4.32–4.53)/1000 person-years in 2005. The incidence of type 1 diabetes remained relatively constant throughout the study period; however, the incidence of type 2 diabetes increased from 2.60 (2.47–2.74)/1000 person-years in 1996 to 4.31 (4.21–4.42)/1000 person-years in 2005. Between 1996 and 2005, the proportion of individuals newly diagnosed with type 2 diabetes who were obese increased from 46% to 56%. Treatment with metformin increased across the study period, while treatment with sulphonylureas decreased.

Conclusions: The prevalence and incidence of type 2 diabetes have increased in the UK over the past decade. This might be primarily explained by the changes in obesity prevalence. Also, there was a change in drug treatment pattern from sulphonylureas to metformin.

Footnotes

  • Competing interests: None.

  • Funding: This study was funded by a unrestricted research grant from AstraZeneca R&D Mölndal, Sweden.

  • Ethics approval: Ethics approval was received from the Multi-centre Research Ethics Committee (MREC)UK-MREC-South-East.

Responses to this article